LeAnn Dourte, Practice Associate Professor in Bioengineering, has been awarded a 2023 Provost’s Award for Teaching Excellence by Non-Standing Faculty.
“This award reflects LeAnn’s innovation and dedication in teaching our students in Bioengineering’s biomechanics, biomaterials and biomechatronics classes and labs,” says Ravi Radhakrishnan, Professor and Chair of Bioengineering. “She is a core member of our teaching faculty, spearheading the Department’s initiatives to improve experiential learning and classroom experiences through the SAIL model of education.”
The Structured, Active, In-Class Learning (or SAIL) model of education emphasizes teamwork and dynamic problem-solving. According to Penn’s Center for Teaching and Learning (CTL), SAIL “provides students with the opportunity to struggle through the application of course ideas and material, often the most difficult part of learning for students, with guidance from instructors as well as help from their peers.”
In addition to her pedagogical interests, Dourte serves on the Bioengineering Climate Committee and is also highly involved in student wellness programming, serving as the Department’s Wellness Ambassador for the School.
The Provost’s Awards for Teaching Excellence by Non-Standing Faculty were established in 1988.
Sharon Kuo, a graduating senior in Mechanical Engineering and Applied Mechanics (MEAM), is the inaugural recipient of the Madison “Maddie” Magee Award for Undergraduate Excellence.
Kuo, who is also minoring in Mathematics, comes to Penn from Taipei, Taiwan. Her interests within her major include mechanical design and product design, and she is passionate about space exploration and advancing human spaceflight.
This award will continue to be presented each year to a Penn Engineering senior who best exemplifies the energy, enthusiasm and excellence that was Maddie.
The award for Undergraduate Excellence was established in honor of Madison “Maddie” N. Magee, who graduated with both a bachelor’s degree in Mechanical Engineering and Applied Mechanics (MEAM) and a master’s degree in Bioengineering (BE) in 2021. Maddie passed away while hiking the Pacific Crest Trail on May 28, 2022. Read more about this award here.
A girl stops by an image of the cosmic microwave background (CMB) at Shanghai Astrology Museum in Shanghai, China Sunday, Jul. 18, 2021. The planetarium, with a total floor space of 38,000 square meters and claimed to be the world’s largest, opens to visitors from July 18. (FeatureChina via AP Images)
There was a time before time when the universe was tiny, dense, and hot. In this world, time didn’t even exist. Space didn’t exist. That’s what current theories about the Big Bang posit, says Vijay Balasubramanian, the Cathy and Marc Lasry Professor of Physics. But what does this mean? What did the beginning of the universe look like? “I don’t know, maybe there was a timeless, spaceless soup,” Balasubramanian says. When we try to describe the beginning of everything, “our words fail us,” he says.
Yet, for thousands of years, humans have been trying to do just that. One attempt came 75 years ago from physicists George Gamow and Ralph Alpher. In a paper published on April 1, 1948, Alpher and Gamow imagined the universe starts in a hot, dense state that cools as it expands. After some time, they argued, there should have been a gas of neutrons, protons, electrons, and neutrinos reacting with each other and congealing into atomic nuclei as the universe aged and cooled. As the universe changed, so did the rates of decay and the ratios of protons to neutrons. Alpher and Gamow were able to mathematically calculate how this process might have occurred.
Now known as the alpha-beta-gamma theory, the paper predicted the surprisingly large fraction of helium and hydrogen in the universe. (By weight, hydrogen comprises 74% of nuclear matter, helium 24%, and heavier elements less than 1%.)
The findings of Gamow and Alpher hold up today, Balasubramanian says, part of an increasingly complex picture of matter, time and space. Penn Today spoke with Balasubramanian about the paper, the Big Bang, and the origin of the universe.
Balasubramanian is Cathy and Marc Lasry Professor in the Department of Physics and Astronomy in the Penn School of Arts and Sciences and a member of the Penn Bioengineering Graduate Group.
Throughout his career, Brian Litt has fabricated tools that support international collaboration, produced findings that have led to significant breakthroughs, and mentored the next generation of researchers tackling neurological disorders. (Image: iStock Photo/Alona Siniehina)
When Brian Litt of the Perelman School of Medicine and School of Engineering and Applied Science began treating patients as a neurologist, he found that the therapies and treatments for epilepsy were mostly reliant on traditional pharmacological interventions, which had limited success in changing the course of the disease.
People with epilepsy are often prescribed anti-seizure medications, and, while they are effective for many, about 30% of patients still continue to experience seizures. Litt sought new ways to offer patients better treatment options by investigating a class of devices that electronically stimulate cells in the brain to modulate activity known as neurostimulation devices.
Litt’s research on implantable neurostimulation devices has led to significant breakthroughs in the technology and has broadened scientists’ understanding of the brain. This work started not long after he came to Penn in 2002 with licensing algorithms to help drive a groundbreaking device by NeuroPace, the first closed-loop, responsive neurostimulator to treat epilepsy.
Building on this work, Litt noted in 2011 how the implantable neurostimulation devices being used at the time had rigid wires that didn’t conform to the brain’s surface, and he received support from CURE Epilepsy to accelerate the development of newer, flexible wires to monitor and stimulate the brain.
“CURE is one of the epilepsy community’s most influential funding organizations,” Litt says. “Their support for my lab has been incredibly helpful in enabling the cutting-edge research that we hope will change epilepsy care for our patients.”
Four University of Pennsylvania undergraduates have received 2023 Goldwater Scholarships, awarded to second- or third-year students planning research careers in mathematics, the natural sciences, or engineering.
They are among the 413 students named 2023 Goldwater Scholars from more than 5,000 students nominated by 427 academic institutions in the United States, according to the Barry Goldwater Scholarship & Excellence in Education Foundation. Each scholarship provides as much as $7,500 each year for as many as two years of undergraduate study.
Penn has produced 59 Goldwater Scholars since Congress established the scholarship in 1986 to honor U.S. Senator Barry Goldwater.
Angela Song (Class of 2024)
Angela Song, from Princeton Junction, New Jersey, is a third-year majoring in bioengineering in the School of Engineering and Applied Science. She is interested in engineering molecular therapeutics for disease. She works in Douglas C. Wallace’s lab in the Center for Mitochondrial and Epigenomic Medicine at the Children’s Hospital of Philadelphia, focusing on designing engineered proteins with mitochondrial applications. At Penn, Song is the vice president of design for UnEarthed, a student-published educational magazine for West Philadelphia elementary school children, and president of the Penn American Red Cross Club. After graduating, Song plans to continue pursuing research through a Ph.D. in bioengineering.
Read the full list of Penn 2023 Goldwater Scholars in Penn Today.
Read about previous Penn Bioengineering Goldwater Scholars here.
Penn Engineering announced the faculty recipients of the 2023 Student Choice Awards (formerly the Teaching and Advising Awards). Each year, the Penn Engineering undergraduate student body thoughtfully selects the recipients of these awards for their dedication in teaching, mentorship and student advocacy. This year also features two new awards, the Student Advocacy Award and the Undergraduate Research Mentoring Award.
Brit Shields, Senior Lecturer in Bioengineering, is the inaugural recipient of the Student Advocacy Award. This award is presented to a member of the Penn Engineering faculty by the Underrepresented Student Advisory Board in Engineering in recognition of their outstanding commitment to women and underrepresented student advocacy, equity and inclusion.
Dr. Shields poses with her award at the annual Penn Engineering Awards Ceremony.
Shields completed a Ph.D. at Penn in 2015 in History and Sociology of Science, with a dissertation on scientific diplomacy through the example of Richard Courant and New York University, where Shields completed an M.A. in Humanities and Social Thought: Science Studies.
She was promoted to Senior Lecturer in Bioengineering in 2019. She has brought her expertise in the history and sociology of science to her leading role in developing and improving the ethics curriculum for all students in the School of Engineering and Applied Science.
Read other stories featuring Brit Shields in the BE Blog.
Read the full list of 2023 Penn Engineering Student Choice Award Winners in Penn Engineering Today.
Gregory Bowman, the Louis Heyman University Professor, has joint appointments in the Department of Biochemistry and Biophysics in the Perelman School of Medicine and the Department of Bioengineering in the School of Engineering and Applied Science. (Image: Courtesy of School of Engineering and Applied Sciences)
His research aims to combat global health threats such as COVID-19 and Alzheimer’s disease by better understanding how proteins function and malfunction, especially through new computational and experimental methods that map protein structures. This understanding of protein dynamics can lead to effective new treatments for even the most seemingly resistant diseases.
“Delivering the right treatment to the right person at the right time is vital to sustaining—and saving—lives,” Magill said. “Greg Bowman’s novel work holds enormous promise and potential to advance new forms of personalized medicine, an area of considerable strength for Penn. A gifted researcher and consummate collaborator, we are delighted to count him among our distinguished PIK University Professors.”
Bowman came to Penn from the Washington University School of Medicine’s Department of Biochemistry and Molecular Biophysics, where he served on the faculty since 2014. He previously completed a three-year postdoctoral fellowship at the University of California, Berkeley.
Bowman’s research utilizes high-performance supercomputers for simulations that can better explain how mutations and disease change a protein’s functions. These simulations are enabled in part through the innovative Folding@home project, which Bowman directs. Folding@home empowers anyone with a computer to run simulations alongside a consortium of universities, with more than 200,000 participants worldwide.
His research has been supported by the National Science Foundation, National Institutes of Health, National Institute on Aging, and Packard Foundation, among others, and he has received a CAREER Award from the NSF, Career Award at the Scientific Interface from the Burroughs Wellcome Fund, and Thomas Kuhn Paradigm Shift Award from the American Chemical Society. He received a Ph.D. in biophysics from Stanford University and a B.S. (summa cum laude) in computer science, with a minor in biomedical engineering, from Cornell University.
“Greg Bowman’s highly innovative work,” Winkelstein said, “exemplifies the power of our interdisciplinary mission at Penn. He brings together supercomputers, biophysics, and biochemistry to make a vital impact on public health. This brilliant fusion of methods—in the service of improving people’s lives around the world—will be a tremendous model for the research of our faculty, students, and postdocs in the years ahead.”
The Penn Integrates Knowledge program is a University-wide initiative to recruit exceptional faculty members whose research and teaching exemplify the integration of knowledge across disciplines and who are appointed in at least two schools at Penn.
The Louis Heyman University Professorship is a gift of Stephen J. Heyman, a 1959 graduate of the Wharton School, and his wife, Barbara Heyman, in honor of Stephen Heyman’s uncle. Stephen Heyman is a University Emeritus Trustee and member of the School of Nursing Board of Advisors. He is Managing Partner at Nadel and Gussman LLC in Tulsa, Oklahoma.
Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer, with AIMBE Fellows representing the top 2% of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”
Nominated and reviewed by peers and members of the College of Fellows, de la Fuente was elected Fellow “for the development of novel antimicrobial peptides designed using principles from computation, engineering and biology.”
A formal ceremony will be held during the AIMBE Annual Event in Arlington, Virginia on March 27, 2023, where de la Fuente will be inducted along with 140 colleagues who make up the AIMBE College of Fellows Class of 2023.
AIMBE Fellows are among the most distinguished medical and biological engineers, including 3 Nobel Prize laureates and 17 Fellows having received the Presidential Medal of Science and/or Technology and Innovation, along with 205 having been inducted into the National Academy of Engineering, 105 into the National Academy of Medicine and 43 into the National Academy of
Sciences.
nucleus and membrane of pathogen micro organisms in blue background
Up to 50 percent of cancer-signaling proteins once believed to be immune to drug treatments due to a lack of targetable protein regions may actually be treatable, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. The findings, published this month in Nature Communications, suggest there may be new opportunities to treat cancer with new or existing drugs.
Researchers, clinicians, and pharmacologists looking to identify new ways to treat medical conditions—from cancer to autoimmune diseases—often focus on protein pockets, areas within protein structures to which certain proteins or molecules can bind. While some pockets are easily identifiable within a protein structure, others are not. Those hidden pockets, referred to as cryptic pockets, can provide new opportunities for drugs to bind to. The more pockets scientists and clinicians have to target with drugs, the more opportunities they have to control disease.
The research team identified new pockets using a Penn-designed neural network, called PocketMiner, which is artificial intelligence that predicts where cryptic pockets are likely to form from a single protein structure and learns from itself. Using PocketMiner—which was trained on simulations run on the world’s largest super computer—researchers simulated single protein structures and successfully predicted the locations of cryptic pockets in 35 cancer-related protein structures in thousands of areas of the body. These once-hidden targets, now identified, open up new approaches for potentially treating existing cancer.
What’s more, while successfully predicting the cryptic pockets, the method scientists used in this study was much faster than previous simulation or machine-learning methods. The network allows researchers to nearly instantaneously decide if a protein is likely to have cryptic pockets before investing in more expensive simulations or experiments to pursue a predicted pocket further.
“More than half of human proteins are considered undruggable due to an apparent lack of binding proteins in the snapshots we have,” said Gregory R. Bowman, PhD, a professor of Biochemistry and Biophysics and Bioengineering at Penn and the lead author of the study. “This PocketMiner research and other research like it not only predict druggable pockets in critical protein structures related to cancer but suggest most human proteins likely have druggable pockets, too. It’s a finding that offers hope to those with currently untreatable diseases.”
William Danon and Luka Yancopoulos pose in front of College Hall in April 2022. They are co-founders of Grapevine and the winners of the 2022 President’s Innovation Prize. (Photo: Eric Sucar)
In April 2022, three President’s Prize-winning teams were selected from an applicant pool of 71 people to develop projects that promote engagement and innovation. Each project received $100,000, as well as a $50,000 living stipend per team member.
The President’s Innovation Prize and President’s Engagement Prize winners included Grapevine, which aims to better connect buyers and suppliers to stabilize the medical supply chain market; IF Ventures, with its mission to scale impact by supporting college students with early-stage startup ideas that have measurable social and environmental impact; and Cosmic Writers, which organizes writing workshops to cultivate K-12 students to be better writers and communicators — and, therefore, better citizens.
“In less than a year, these three PIP and PEP prize-winning teams have already proven their commitment to making a difference in the world,” says President Liz Magill. “Their projects are ambitious and inspiring, and I am proud the University has been able to provide financial and networking support for these determined changemakers.”
After graduating in May 2022, Luka Yancopoulos, an Environmental Studies major and a Bioengineering major in the School of Engineering and Applied Science and William Danon, a History major, relocated to an office space in Westchester, New York, and got to work on a research and validation process — first, by spending a day at a Penn Medicine facility, Lancaster General Health, then by committing hundreds of hours to interviewing distributor and procurement teams alike, along with potential client companies. The mission, as any researcher knows, was to understand key pain points. They also onboarded veterans in logistics, technology, and payment security and processing while devising an organizational structure in which Yancopoulous leads on technology and design solutions while Danon interfaces with customers to know what needs remain unmet.
Grapevine soft launched in fall 2022 and, they say, has interfaced with 30 companies through its digital platform to facilitate sales among 40 suppliers, amounting to more than $20,000 in transactions. The appeal of the platform, they say, remains the concept of the “digital supply chain network,” which Yancopoulos says partners can use to connect with resellers, hospitals, distributors, and others to reduce the risk of supply chain disruption that is not just a product of the pandemic, he adds, but “forever ongoing.”
“It’s driven by the principle that together we’re stronger, and I mean that in every aspect of my life,” he says. “That people are stronger, and with Grapevine we work to [bolster] supply chains and increase the accessibility of health care products — together.”
Since winning the President’s Innovation Prize, they’ve focused on working with small- to medium-sized businesses — whether local clinics or high-quality, specialized resellers — that struggle to compete with or pay for traditional, large-scale distributors that are better-resourced or too expensive. It’s allowed them to also find new users, like health care-adjacent businesses including funeral homes and tattoo parlors.
Their current tagline: “Grow with us,” Danon says.
Watch a video overview of Grapevine’s progress since receiving the PIP prize and read more about the other PIP/PEP prize winners at Penn Today.
